The clinical significance of detection of residual disease in childhood ALL
- 1 June 1998
- journal article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 28 (1) , 31-55
- https://doi.org/10.1016/s1040-8428(98)00008-0
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clonespecific or malignancy-specific gene markersCancer Genetics and Cytogenetics, 1996
- The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 1989
- Human leukocyte IgG Fc receptorsImmunology Today, 1986
- Detection of Residual Acute Lymphoblastic Leukemia Cells in Cultures of Bone Marrow Obtained during RemissionNew England Journal of Medicine, 1986
- Presence of Clonal Chromosome Abnormalities in Virtually All Cases of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1985
- YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1984
- Frequency of bone marrow aspirates to monitor acute lymphoblastic leukemia in childhoodThe Journal of Pediatrics, 1983
- Predicting Relapse of Human Leukemia by Means of Premature Chromosome CondensationNew England Journal of Medicine, 1980
- Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent traumaThe Journal of Pediatrics, 1978
- Pre-B-Cell LeukemiaNew England Journal of Medicine, 1978